Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Deferred Revenue: 2019

Historic Current Deferred Revenue for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2019 value amounting to -$2,340.

  • ADC Therapeutics' Current Deferred Revenue was N/A to -$2,340 in Q4 2019 from the same period last year, while for Dec 2019 it was -$2,340, marking a year-over-year change of. This contributed to the annual value of -$2,340 for FY2019, which is N/A change from last year.
  • Latest data reveals that ADC Therapeutics reported Current Deferred Revenue of -$2,340 as of Q4 2019, which was down 0.00% from -$2,340 recorded in Q3 2019.
  • ADC Therapeutics' Current Deferred Revenue's 5-year high stood at -$2,340 during Q2 2019, with a 5-year trough of -$2,340 in Q2 2019.
  • Moreover, its 1-year median value for Current Deferred Revenue was -$2,340 (2019), whereas its average is -$2,340.